Agenda


The GFIC2017 program will begin following the 10th China Biosciences Annual Conference on July 3, 2017.  It will be divided into two major sessions: Keynotes and Panels on the afternoon of July 3, and Roadshow Presentations on the morning of July 4.

Location: Shantou Room, 2F, Building #2
                Guangzhou Baiyun International Convention Center
                No. 1039-1045 Baiyun Avenue, South, Baiyun District, Guangzhou
                Guangdong 510405, China

Day 1 - Monday, July 3, 2017
时间
Time
议程
Title/Description
拟邀嘉宾
Speakers
14:00-14:10 欢迎致辞
Welcoming Remarks
曾浩 广发信德董事长
Dr. Hao Zeng - Chairman, GF Xinde
14:10-14:35 主题演讲-新时代中国药品监管思路剖析
Keynote 1 - An Interpretation of China's Regulatory Policy Reforms on Innovative Medicine
丁建华 药化监管司司长
Jianhua Ding - Director-General, Department of Drug and Cosmetics Registration, CFDA
14:35-15:00 主题演讲-中国药审改革政策解读
Keynote Speech 2- Interpretation of China 's Drug Reform Policy
朱迅  同写意新药英才俱乐部理事长,国家新药审评委员会专家
Xun Zhu-Director of Tongxieyi New Drug Club, National New Drug Review Committee experts
15:00-15:45 圆桌论坛-加入ICH,中国创新如何走向世界
Panel Discussion – How Will China's Path to Innovation be Spurred by its Membership in the ICH?
主持人
Moderator: 
程增江 同写意论坛发起人
Zengjiang Cheng - Secretary-General, Tongxieyi
嘉宾:
Panelists:
丁建华 药化监管司司长
Jianhua Ding - Director-General, Department of Drug and Cosmetics Registration, CFDA
博济医药董事长王廷春
Yanchun, Wang - Chairman, Boji Pharmaceutical
杜涛  前FDA评审专家
Tao Du-former FDA review experts
15:45-16:00 茶歇与交流
Networking Break
16:00-16:20 主题演讲-医药创新,智赢未来
Keynote 3 - Pharmaceutical innovation, wisdom to win the future
席庆 辉瑞中国政府事务、市场准入及企业沟通部高级总监
Qing Xi- Senior Director in China Government Affairs, Market Access and Corporate Communications of Pfizer
16:20-17:05 圆桌论坛-跨国药企的中国策略
Panel Discussion – 2017 Cross Border Investment Opportunities and Challenges
主持人
Moderator: 
David Beier  BCC合伙人
David Beier, JD - Partner, Bay City Capital
嘉宾
Panelists:
吴锋 辉瑞中国区副总裁
Feng Wu - Vice President, Pfizer China
罗永庆 吉利德中国区总裁
Roger Luo - CEO, Gilead China
Greg B. Scott  ChinaBio创始人
Greg B. Scott  -the Founder of ChinaBio
Micky Tortorella 中科院广州生物医药与健康研究院CTO
Micky Tortorella -CTO of Guangzhou Institute of Biomedicine and Health, Chinese Academy of Sciences
Benjamin Chen  DRW 董事会成员、管理合伙人
Benjamin Chen -Board of Directors, Managing Partner in DRW
17:05-17:25 主题演讲-欧美生物医药投融资的过去与未来
Keynote 3 – US China Partnerships and M&A Opportunities
Fred Craves  BCC合伙人
Fred Craves - Partner, Bay City Capital
17:25-18:10 圆桌论坛-生物医药跨境投资的机遇与挑战
Panel Discussion – Future of Offshore Healthcare Investments
主持人
Moderator: 
罗佳荣 广发医药首席研究员
Jiarong Luo -the Chief Analyst of Development Research Center in GF Securities
嘉宾:
Panelists:
Fred Craves  BCC创始人
Fred Craves - Founder of BCC
肖雪生  广发信德总经理
Xuesheng Xiao - GM, GF Xinde
沈亚平 恒瑞医药副总经理
Yaping Shen - Deputy General Manager of Hengrui Medicine 
Bob Ai  Trout Group
Bob Ai, PhD, MBA - Senior Vice President, Trout Group
 宋涛  东莞生技公司董事长 
Tao Song-Chairman of the Board of Dongguan Biological Technology Development Co. Ltd
Day 2 - Tuesday July 4, 2017
时间 
Time
议程
Description 
发言代表
Presenter
8:30-8:50 创新药物的中美双报策略
Sino - US Double - Report Strategy for Innovative Drugs
杜涛  前FDA评审专家
Tao Du-former FDA review experts
8:50-10:10 海外创新药物/技术
Overseas Innovative Drugs / Technology
8:50-9:10 Twist Dr Chris Tan
9:10-9:30 DRW Benjamin Chen
9:30-9:50 Targovax  Erik Digman Wiklund
9:50-10:10 Phagelux Mark Engel
10:10-10:20 茶歇
Networking Break
10:20-12:30 中国生物医药创新力量
 Innovation Force in China 's Biomedical
10:20-10:40 索元生物
Denovo Biopharma
罗文
Wen Luo
10:40-11:00 柯菲平医药
Carephar
金秋
Qiu Jin
11:00-11:20 阳光诺和药物研究
Beijing Sun-Novo pharmaceutical
罗桓
Huan Luo
11:20-11:40 太美医疗
Taimei Technology
赵璐
Lu Zhao
11:40-12:00 诺唯赞生物
Vazyme Biotech Co.,
Ltd
曹林
Lin Cao
12:00-12:20 瑞博奥生物
RIBIO TECH
黄若磐
Ruoban Huang
12:20-12:30 结束致辞
Closing Remarks
肖雪生 广发信德总经理
Xuesheng Xiao - General manager, GF Xinde

 

 Host

 Co-organizers